News & Updates

Sildenafil orally disintegrating strips (ODS) are just as effective and safe as the conventional tablet formulation for the treatment of erectile dysfunction (ED), a Thai study suggests.

Electronic nicotine delivery devices (ENDS) or e-cigarettes appear to be detrimental to men, with a recent study suggesting that its use contributes to a heightened risk of erectile dysfunction.

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).

Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.

Among patients with metastatic renal cell carcinoma, there are multiple factors that affect overall survival, including race, gender, treatment, and socioeconomic factors, as reported in a study.

Fusion biopsy with magnetic resonance imaging and ultrasonography (MRI/US) is an efficient method of detecting clinically significant prostate cancer (csPCa) in biopsy-naïve men with prostate specific antigen (PSA) levels 4–10 ng/mL, a new study has found.

A low carbohydrate diet (LCD) may substantially reduce the risk of metabolic syndrome (MetS) and remnant cholesterol in patients with prostate cancer, a recent study has shown.

Reduced-dose treatment with androgen receptor pathway inhibitors (ARPI) lead to poorer oncological outcomes relative to full-dose regimens in castration-resistant prostate cancer (CRPC), a recent study has found.